Maternal Influenza Vaccination and the Risk of Laboratory-Confirmed Influenza Among Household Contacts Under the Age of Five in Mali.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 12 12 2018
medline: 17 10 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Influenza transmission is increased among household contacts. Vaccination decreases transmission; however it is unclear how vaccinating a single individual alters disease risk among household contacts, particularly in regions with low vaccination coverage. Pregnant women were randomized to influenza or control vaccination. Households were visited weekly until infants born to enrolled women reached 6 months. Household contacts younger than 5 years were tested for laboratory-confirmed influenza (LCI). Incidence of LCI and rate ratios (RtR) comparing incidence between vaccine groups were calculated. The secondary infection rate (SIR) was calculated for households where LCI was detected. The H1N1 strain in the vaccine was a match for circulating H1N1 during the study, thus, all analyses were performed for H1N1-LCI and any LCI. A total of 5,345 household contacts younger than 5 years followed for a mean of 228 days (standard deviation [SD] = 45 days) experienced 2,957 influenza-like illness episodes. Incidence of any LCI and H1N1-LCI was 23 (

Identifiants

pubmed: 30526742
doi: 10.4269/ajtmh.18-0450
pmc: PMC6335916
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-164

Références

Clin Infect Dis. 2018 Mar 5;66(6):865-876
pubmed: 29045699
JAMA. 2000 Oct 4;284(13):1677-82
pubmed: 11015798
Glob Heart. 2014 Sep;9(3):325-36
pubmed: 25667184
Sci Rep. 2014 Nov 27;4:7218
pubmed: 25427621
J Infect Dis. 2015 Sep 1;212(5):740-4
pubmed: 25722293
Clin Infect Dis. 2013 Dec;57(11):1520-6
pubmed: 24046313
JAMA. 2001 Feb 14;285(6):748-54
pubmed: 11176912
Virol J. 2014 Jan 27;11:13
pubmed: 24468218
Trends Microbiol. 2016 Feb;24(2):123-133
pubmed: 26612500
J Infect. 2015 Nov;71(5):578-86
pubmed: 26366941
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
N Engl J Med. 2010 Jun 10;362(23):2175-2184
pubmed: 20558368
Clin Microbiol Infect. 2012 Oct;18(10):976-81
pubmed: 22221838
BMC Med. 2012 Oct 09;10:117
pubmed: 23046520
Am J Epidemiol. 2007 Jan 15;165(2):212-21
pubmed: 17088311
Br J Gen Pract. 2004 Sep;54(506):684-9
pubmed: 15353055
JAMA. 2010 Mar 10;303(10):943-50
pubmed: 20215608
Curr Opin Infect Dis. 2013 Jun;26(3):248-53
pubmed: 23507974
Lancet. 2011 Dec 3;378(9807):1917-30
pubmed: 22078723
Influenza Other Respir Viruses. 2015 Aug;9 Suppl 1:31-7
pubmed: 26256293
Epidemics. 2013 Dec;5(4):181-6
pubmed: 24267874
PLoS One. 2012;7(2):e31519
pubmed: 22359599
PLoS One. 2011 Feb 17;6(2):e17207
pubmed: 21359150
Curr Opin Pediatr. 2012 Feb;24(1):92-7
pubmed: 22157361
Am J Trop Med Hyg. 2018 Jun;98(6):1805-1810
pubmed: 29663903
BMC Infect Dis. 2014 Sep 04;14:480
pubmed: 25186370
Lancet Infect Dis. 2016 Sep;16(9):1026-1035
pubmed: 27261067
Ann Intern Med. 2009 Oct 6;151(7):437-46
pubmed: 19652172
J Infect. 2014 Jun;68(6):581-90
pubmed: 24491598
PLoS One. 2013 Apr 18;8(4):e61909
pubmed: 23637928

Auteurs

Andrea G Buchwald (AG)

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland.

Boubou Tamboura (B)

Centre pour le Développement des Vaccins-Mali, Bamako, Mali.

Fadima C Haidara (FC)

Centre pour le Développement des Vaccins-Mali, Bamako, Mali.

Flanon Coulibaly (F)

Centre pour le Développement des Vaccins-Mali, Bamako, Mali.

Moussa Doumbia (M)

Centre pour le Développement des Vaccins-Mali, Bamako, Mali.

Fatoumata Diallo (F)

Centre pour le Développement des Vaccins-Mali, Bamako, Mali.

Sarah Boudova (S)

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland.

Adama M Keita (AM)

Centre pour le Développement des Vaccins-Mali, Bamako, Mali.

Samba O Sow (SO)

Centre pour le Développement des Vaccins-Mali, Bamako, Mali.

Karen Kotloff (K)

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland.

Myron Levine (M)

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland.

Milagritos D Tapia (MD)

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH